verapamil has been researched along with Anochlesia in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The ability of CCBs to produce catalepsy in mice was also evaluated in the study." | 1.36 | Anti-psychotic and sedative effect of calcium channel blockers in mice. ( Bakre, TO; Onwuchekwa, C; Umukoro, S, 2010) |
| "Antagonism of haloperidol catalepsy by 10 mg/kg verapamil is also explained on the basis of presynaptic D2 DA autoreceptor induced blockade by 10 mg/kg verapamil whereas potentiation of haloperidol catalepsy by 20 mg/kg verapamil is explained on the basis of its calcium channel blocking activity." | 1.30 | EFFECTS OF VERAPAMIL ON DOPAMINE DEPENDENT BEHAVIOURS IN RATS. ( Balsara, JJ; Gaonkar, RK; Malekar, AR, 1999) |
| "Intensity of catalepsy was predicted by dopamine D1, D2, and mACh receptor occupancies with the dynamic model which had already been constructed and was compared with the observed values." | 1.30 | Catalepsy induced by calcium channel blockers in mice. ( Haraguchi, K; Iga, T; Ito, K; Kotaki, H; Sawada, Y, 1998) |
| "2." | 1.30 | Evidence of sex related differences in the effects of calcium channel blockers on neuroleptic-induced catalepsy in mice. ( Amorim, SC; Costa, PG; Futuro-Neto, HA; Pires, JG; Ribeiro, CA; Saraiva, FP, 1999) |
| "All these drugs reduced the onset of catalepsy, significantly increased the cataleptic score and delayed the onset and inhibited the Methamphetamine-induced stereotypy." | 1.29 | Effect of pre-treatment of some calcium channel blockers on catalepsy and stereotypic behaviour in rats. ( Belorkar, NR; Khanzode, SD; Kharkar, VT; Mahakalkar, SM; Manekar, MS, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malekar, AR | 1 |
| Balsara, JJ | 1 |
| Gaonkar, RK | 1 |
| Umukoro, S | 1 |
| Bakre, TO | 1 |
| Onwuchekwa, C | 1 |
| Khanzode, SD | 1 |
| Mahakalkar, SM | 1 |
| Belorkar, NR | 1 |
| Kharkar, VT | 1 |
| Manekar, MS | 1 |
| Haraguchi, K | 1 |
| Ito, K | 1 |
| Kotaki, H | 1 |
| Sawada, Y | 1 |
| Iga, T | 1 |
| Futuro-Neto, HA | 1 |
| Costa, PG | 1 |
| Amorim, SC | 1 |
| Saraiva, FP | 1 |
| Ribeiro, CA | 1 |
| Pires, JG | 1 |
5 other studies available for verapamil and Anochlesia
| Article | Year |
|---|---|
EFFECTS OF VERAPAMIL ON DOPAMINE DEPENDENT BEHAVIOURS IN RATS.
Topics: Animals; Apomorphine; Avoidance Learning; Catalepsy; Dopamine; Haloperidol; Male; Rats; Receptors, D | 1999 |
Anti-psychotic and sedative effect of calcium channel blockers in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Calcium Channel Blockers; Catalepsy; Disease Models, Ani | 2010 |
Effect of pre-treatment of some calcium channel blockers on catalepsy and stereotypic behaviour in rats.
Topics: Animals; Calcium Channel Blockers; Catalepsy; Central Nervous System Depressants; Central Nervous Sy | 1996 |
Catalepsy induced by calcium channel blockers in mice.
Topics: Amlodipine; Animals; Binding, Competitive; Calcium Channel Blockers; Catalepsy; Dihydropyridines; Di | 1998 |
Evidence of sex related differences in the effects of calcium channel blockers on neuroleptic-induced catalepsy in mice.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Calcium Channel Blockers; Catalepsy; Dose-Res | 1999 |